News

This thesis of Hendrea Tingen investigates how nuclear imaging can improve the diagnosis, monitoring of disease progression, and evaluation of treatment response in…

The U.S. Food and Drug Administration (FDA) has lifted a clinical hold on a Phase 3 clinical trial testing the investigational gene-editing therapy, nexiguran…

Accurate identification of the amyloid fibril protein is the critical first step in the diagnostic pathway for any patient with amyloidosis.Service Overview …

Event DetailsMarch is Amyloidosis Awareness Month, dedicated to raising awareness of this rare disease, emphasizing the importance of early diagnosis, and…

Event DetailsWednesday, February 11, 2026, 5:00 - 6:30 PM ESTThe Door163-07 Baisley Blvd, Jamaica, NYHosted by: Christopher OrtizProgram Topic: Hereditary ATTR (…

Overview This is a prospective case control study to determine the feasibility and utility of myocardial stiffness assessment by cardiac magnetic resonance…

About youDo you want to use your skills to make it possible for people with myeloma to live longer and better lives? Are you an experienced event organiser looking…

More than half of adults with hereditary ATTR amyloidosis with cardiomyopathy (hATTR-CM), a condition marked by heart damage, also have multi-nerve damage,…

More than half of adults with hereditary ATTR amyloidosis with cardiomyopathy (hATTR-CM), a condition marked by heart damage, also have multi-nerve damage,…

The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of the bone…